1,2,3,9-四氢-9-甲基-3-[（2-甲基-1H-咪唑-1-基）甲基] -4H-咔唑-4-酮盐酸盐

产品名称：

103639-04-9
Ondansetron for TLC system suitability
1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one hydrochloride
GR 38032F
Ondansetron Hydrochloride Dihydrate
昂丹司琼
昂丹司琼盐酸盐二水合物
1,2,3,9-四氢-9-甲基-3-[（2-甲基-1H-咪唑-1-基）甲基] -4H-咔唑-4-酮盐酸盐

产品介绍：

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

5-HT₃ 血清素受体拮抗剂

包装

Unit quantity: 20 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式	C₁₈H₁₉N₃O · HCl · 2H₂O
分子量	365.85
MDL编号	MFCD00374371
PubChem化学物质编号	329830878
NACRES	NA.24

产品性质

等级	pharmaceutical primary standard
manufacturer/tradename	EDQM
application(s)	pharmaceutical (small molecule)
格式	neat
储存温度	2-8℃
SMILES string	Cl[H].[H]O[H].[H]O[H].Cc1nccn1CC2CCc3c(C2=O)c4ccccc4n3C
InChI	1S/C18H19N3O.ClH.2H2O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2;;;/h3-6,9-10,13H,7-8,11H2,1-2H3;1H;2*1H2
InChI key	VRSLTNZJOUZKLX-UHFFFAOYSA-N
Gene Information	human ... HTR3A(3359)

安全信息

象形图
警示用语：	Danger
危险声明	H301 - H318 - H410
预防措施声明	P264 - P270 - P273 - P280 - P301 + P310 - P305 + P351 + P338
危险分类	Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Dam. 1
储存分类代码	6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable